Straight to you, Julie. Okay. Thank you very much. Thanks James. So, in terms of -- I see a competitive P&L as one that's operating to full capacity and making optimal use of the resources in the business and capital allocation in the business. And I think good progress has been made in GSK already following the separation with the future ready program. And working with Tony closely because, obviously, I've been in the pharma industry for a long time and worked with R&D for a long time. Clearly, investment ...